Jul 27th 2023
Schizoaffective disorder is a chronic mental health condition that combines features of both schizophrenia and mood disorders, such as bipolar disorder or major depressive disorder. It is characterized by a combination of psychotic symptoms, such as delusions and sometimes hallucinations, as well as symptoms of mood disorders, such as mania or depression. 
Schizoaffective disorder is generally considered to be a lifelong condition with no cure. It typically emerges in late adolescence or early adulthood, and it often requires ongoing treatment and management.
Individuals with schizoaffective disorder may experience periods of stability with milder symptoms, but they can also have episodes of more severe symptoms, including psychotic episodes and mood disturbances.
There is evidence to suggest that people with schizoaffective disorder may have a reduced life expectancy when compared to the general population.
A 2011 study asserted that the average life expectancy at birth was 69.4 for men and 64.1 for women diagnosed with schizoaffective disorder.  These figures are 8 and 17.5 years less than the life expectancy of an average man or woman, respectively. 
Whilst life expectancy acts as useful metric to medical professionals and policymakers in the combatting of diseases, it is primarily a measure of impact rather than effect.  As such, it is important to understand that various risk factors, such as lifestyle conditions and medical comorbidities, can contribute to this gap in life expectancy.
The hope is that with an increased focus on treatment, a spreading of awareness and knowledge about the disease and better healthcare options for everyone across society – people with schizoaffective disorders will be able to live longer and more fulfilling lives.
Several factors can contribute to the reduced life expectancy among individuals with schizoaffective disorder:
It is important to note that individual circumstances and factors vary, and not everyone with schizoaffective disorder will experience a reduced life expectancy.
With an effective treatment plan, support, and management of both mental and physical health, individuals with schizoaffective disorder can lead fulfilling lives and improve their overall well-being, potentially mitigating the impact on life expectancy.
Early diagnosis, comprehensive treatment, regular monitoring of physical and mental health, and a holistic approach to care can help address these factors and improve the overall health outcomes and life expectancy for individuals with schizoaffective disorder.
Treatment for schizoaffective disorder typically involves a combination of medication, such as antipsychotics, mood stabilizers, or antidepressants, to manage symptoms.  Always consult a doctor before embarking on any course of medication. They will provide guidance on dosage and regular check-ups to ensure medication is not having an adverse impact on your health. 
Art, dance, music or acting therapies may help a patient express how they are feeling and interact with others . These may be especially beneficial when someone struggles to talk about their issues.
With appropriate treatment and support, many individuals with schizoaffective disorder can lead fulfilling and productive lives. However, it is important to recognize that ongoing management and support are generally necessary to help individuals effectively manage their symptoms and maintain overall well-being.
MentalHealth.com is a patient-first technology company driven by its mission to make optimal mental health attainable for everyone. With a focus on expanding care access, empowering choice, and enhancing care quality, the company delivers innovative solutions that support individuals throughout their mental health journey.
Our Medical Affairs Team is a dedicated group of medical professionals with diverse and extensive clinical experience who actively contribute to the development of our content, products, and services. They meticulously evaluate and review all medical content before publication to ensure it is medically accurate and aligned with current discussions and research developments in mental health. For further information, please visit our Editorial Policy.